[Asthma therapy with a combination of synthetic antimalarials (83 cases)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy*; D002738:Chloroquine / Q000008:administration & dosage* / Q000009:adverse effects; D004357:Drug Synergism; D004562:Electrocardiography; D004802:Eosinophilia / Q000139:chemically induced; D005132:Eye Manifestations; D005938:Glucocorticoids / Q000009:adverse effects; D006801:Humans; D008875:Middle Aged; D011736:Pyridoxine / Q000008:administration & dosage; D011796:Quinacrine / Q000008:administration & dosage* / Q000009:adverse effects; D013566:Sympathomimetics / Q000009:adverse effects; D014803:Vitamin B Complex / Q000008:administration & dosage
D005938:Glucocorticoids; D013566:Sympathomimetics; D014803:Vitamin B Complex; D002738:Chloroquine; D011796:Quinacrine; D011736:Pyridoxine
Thérapeutique de l'asthme par association d'anti-malariques de synthèse (83 cas)